Faculty of Pharmacy Universitas Indonesia

What Faculty of Pharmacy Universitas Indonesia does

Faculty of Pharmacy Universitas Indonesia (FFUI) is a public university faculty within Universitas Indonesia, headquartered at the Rumpun Ilmu Kesehatan (RIK) complex on the UI Depok campus in Indonesia. The faculty delivers pharmaceutical education across five programs: a Bachelor's degree in Pharmacy (S1), a Professional Pharmacist program (Apoteker), Master's programs in Pharmaceutical Sciences and Herbal Medicine (S2), and a Doctoral program in Pharmaceutical Sciences (S3). It operates research laboratories including cell culture facilities and an ethics committee, supports research clusters across pharmaceutical sciences domains, and hosts the annual ICAPPS international conference. FFUI is ranked #2 in Indonesia and #14 in Southeast Asia for Pharmacy & Pharmacology in the QS World University Rankings 2026, and is #301-350 worldwide.

FFUI's business model is that of a public state university faculty rather than a commercial enterprise. Its funding streams consist of government budget allocations (DIPA) routed through Universitas Indonesia and the Ministry of Education and Culture, recurrent student tuition under the government-subsidized UKT (Uang Kuliah Tunggal) system, and external research grants from DIKTI, UI, BRIN, and international partners. Publication assistance funding is also provided internally (up to Rp35M for Q1 journals). The faculty does not publicly disclose financial figures. Its go-to-market is via Indonesia's national university admission system (SNBT/SNPMB) for domestic students, with international recruitment starting in 2027 through Virtual Open House events and double-degree pathways with University of Queensland, NAIST Japan, and Chulalongkorn University. Customer segments are horizontal: domestic undergraduate students, professional pharmacist candidates, master's and doctoral researchers, international students (forthcoming), and practicing pharmacists seeking continuing education.

The faculty's underlying technical capability centers on pharmaceutical sciences research — drug delivery systems, pharmaceutical biotechnology, natural products, and health innovation — with emerging work in pharmacist-led digital health interventions for asthma and COPD via the INUCoST collaboration with Leiden University, and exploratory AI-driven drug discovery with Bionyeri Pty Ltd Australia. Industry partnerships with PT Cosmax Indonesia and PT Martha Tilaar Group support cosmetic and pharmaceutical product development. Leadership transitioned in December 2025 to Prof. apt. Silvia Surini, M.Pharm.Sc., Ph.D. as Dean for the 2025-2029 term, with announced priorities including establishment of an International Class and construction of a new faculty building.

Name

Faculty of Pharmacy Universitas Indonesia

Legal name

Fakultas Farmasi Universitas Indonesia

Website

https://farmasi.ui.ac.id

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Faculty of Pharmacy Universitas Indonesia (FFUI) is a public university faculty offering pharmaceutical education (bachelor's through doctoral) and professional pharmacist training, serving domestic and international students and conducting pharmaceutical sciences research.

Ownership category

akta.pro rank

Product category

Higher Education - Pharmaceutical Sciences

NAICS

Colleges, Universities, and Professional Schools (6113), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Schools of Pharmacy (EDAHAGAE)

akta.pro secondary industries

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Pharmaceutical education
• Pharmacy degree programs
• Pharmaceutical sciences research
• Drug delivery systems
• Herbal medicine research

Headquarters

HQ city

Depok

HQ country

Indonesia

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Government Budget (DIPA): Public university funded by government allocation from Ministry of Education and Culture through Universitas Indonesia
2. Student Tuition Fees (UKT): Uang Kuliah Tunggal (UKT) charged to students for educational services across all study programs
3. Research Grants and Funding: External funding from DIKTI, UI, and international collaborations for research activities
4. Publication Assistance Funding: Internal funding support for faculty publication in international journals (Q1 up to Rp35M, Q2 up to Rp15M)

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

FFUI is a public university faculty that delivers pharmaceutical education across five degree programs: Undergraduate Pharmacy (S1 Sarjana), Professional Pharmacist (Apoteker), Master's in Pharmaceutical Sciences (S2), Master's in Herbal Medicine (S2), and Doctoral in Pharmaceutical Sciences (S3). The faculty supports pharmaceutical research through organized clusters in drug delivery, biotechnology, natural products, and digital health, and operates research laboratories, cell culture facilities, and the UKK Pharma UI commercial venture unit.

Product overview

Faculty of Pharmacy Universitas Indonesia (FFUI) is an academic institution within Universitas Indonesia offering a comprehensive portfolio of pharmacy education programs spanning undergraduate (Sarjana), professional (Apoteker/Pharmacist), master's (Magister), and doctoral (Doktor) levels. The faculty operates research clusters, laboratories, and various academic services supporting education in pharmaceutical sciences, herbal medicine, drug delivery systems, and quality control. FFUI collaborates with international universities and industry partners for research and student exchange programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Program Studi Sarjana Farmasi (Bachelor's Program in Pharmacy) Undergraduate degree program in pharmacy that prepares students for careers in pharmaceutical sciences, drug development, and healthcare. It provides a foundation for the professional pharmacist track or further graduate studies.
• Program Studi Profesi Apoteker (Professional Pharmacist Program) Professional program that prepares graduates to become licensed pharmacists, including clinical training and competency assessment in preparation for the national UKMPPAI examination.
• Program Studi Magister Ilmu Kefarmasian (Master's in Pharmaceutical Sciences) Master's degree program focused on advanced pharmaceutical sciences research and expertise.
• Program Studi Magister Herbal (Master's in Herbal Sciences) Master's degree program specializing in herbal medicine, natural products, and complementary medicine.
• Program Studi Doktor Ilmu Farmasi (Doctoral Program in Pharmaceutical Sciences) Doctoral research program producing PhD graduates in pharmaceutical sciences with advanced research capabilities.

Quantifiable outcome

• 235 graduates produced in Semester Genap 2024/2025 across all programs
• +3 more outcomes

Named customers12 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

15 partnerships are on record, tiered core, strategic and minor.

• Badan POM (BPOM RI)coreStrategic or Co-development PartnerOngoing collaboration on OBASKK (Obat Bahan Alam, Suplemen Kesehatan, Kosmetik) cadre formation, public education, pharmacovigilance guest lectures, and regulatory training. BPOM Head served as Ko-Promotor for doctoral dissertation on natural medicine policy.
• Kementerian Kesehatan RI (Kemenkes)coreStrategic or Co-development PartnerCollaboration on health monitoring, pharmaceutical ecosystem management, and policy discussions. Dirjen Farmalkes conducted guest lecture on health project monitoring and controlling mechanisms.
• Nara Institute of Science and Technology (NAIST) JapanstrategicStrategic or Co-development PartnerExploring double degree program for doctoral studies, international guest lectures on micro/nanofluidic technology for drug development, potential research collaboration on biotechnology.
• University of Queensland AustraliastrategicStrategic or Co-development PartnerExecutive meetings on international collaboration, guest lecture on cancer drug discovery and TRPV6 ion channels, discussions on Master of Pharmaceutical Industry Practice program and joint/double degree opportunities.
• Bionyeri Pty Ltd AustraliastrategicStrategic or Co-development PartnerExploratory collaboration on natural product development for neuroscience, molecular docking, and AI-driven drug discovery. Matchmaking research interest grant obtained, with planned facility visit in April 2026.
• Chulalongkorn University ThailandstrategicStrategic or Co-development PartnerInternational collaboration on education and research in pharmaceutical sciences, student exchange programs, and AASP-CPDT Summer School participation opportunities.
• SGT University IndiaminorStrategic or Co-development PartnerStudy visit for benchmarking academic quality and exploring strategic collaboration opportunities between pharmacy faculties.
• PT Cosmax IndonesiastrategicStrategic or Co-development PartnerProgress discussion on ongoing pharmaceutical and cosmetic product development partnership, regular collaboration meetings.
• PT Martha Tilaar GroupminorStrategic or Co-development PartnerExploring collaboration opportunities in pharmacy and cosmetics tridharma implementation including education, research, and community service.
• Indonesia-Netherlands Universities Consortium for Sustainable Futures (INUCoST)strategicStrategic or Co-development Partner3-year funded research collaboration with Prof. Niels Chavannes (Leiden University) on Pharmacist-Led Digital Health Intervention for Asthma and COPD, leveraging NeLL platform.
• Badan Riset dan Inovasi Nasional (BRIN)coreStrategic or Co-development PartnerFacilitated international research collaborations and matchmaking between FFUI and Bionyeri Australia through BRIN's international network.
• Universitas Islam Sultan Agung (UNISSULA)minorStrategic or Co-development PartnerMoU implementation for Tri Dharma collaboration, monitoring of lecturers pursuing advanced studies at FFUI, potential guest lecture support.
• Universitas Fort De KockminorStrategic or Co-development PartnerStudy visit for accreditation preparation, sharing of best practices in Laporan Evaluasi Diri (LED) compilation and academic governance.
• The Society of Indonesian Cosmetic Scientists (SICS)minorStrategic or Co-development PartnerCo-hosting SICS scientific seminar on cosmetic formulation innovation based on science and international standards.
• Universitas Indonesia Directorate of Funding and Research Ecosystem (DPER)coreStrategic or Co-development PartnerInternal funding support for international publication assistance (up to Rp35M for Q1 journals), research grants, and Lindau Nobel delegate recognition.

Scale indicators7 records

Regional players

• School of Pharmacy, University of Queensland: Australia-based pharmacy school with which FFUI has a strategic partnership for joint/double degrees and research collaboration. Comparable in pharmaceutical research output, with significant overlap in drug discovery and natural product research focus areas.
• Department of Pharmacy, National University of Singapore: Singapore's premier pharmacy department with strong research output in pharmaceutical sciences and clinical pharmacy. Regional peer for benchmarking research quality, international student recruitment, and industry partnerships.
• Faculty of Pharmaceutical Sciences, Chulalongkorn University: Thailand's leading pharmacy school and an FFUI strategic partner. Comparable in scale and research depth, with similar international collaborations and a national regulatory authority partnership. Serves as a regional benchmark for pharmaceutical education in Southeast Asia.
• Faculty of Pharmacy, Mahidol University: Another top-ranked pharmacy school in Southeast Asia with full S1-S3 program offerings and strong pharmaceutical sciences research. Regional peer for benchmarking internationalization and research productivity.
• Faculty of Pharmacy and Pharmaceutical Sciences, Monash University: Australia-based pharmacy school with strong research in pharmaceutical sciences and drug discovery. Comparable in scale and international orientation, with industry partnerships that mirror FFUI's PT Cosmax and PT Martha Tilaar engagements.

Direct peers

• School of Pharmacy, Institut Teknologi Bandung (ITB): ITB's pharmacy program is a leading competitor in Indonesia with strong research orientation, particularly in drug delivery and pharmaceutical technology. Comparable undergraduate-to-doctoral pharmacy education pipeline and similar industry partnerships.
• Faculty of Pharmacy, Universitas Gadjah Mada (UGM): The other top-tier pharmacy faculty in Indonesia, regularly competing with FFUI for the #1 national QS ranking. Offers similar S1-S3 pharmacy programs and serves as the most direct domestic competitor for students, faculty talent, and research grants.
• Faculty of Pharmacy, Universitas Padjadjaran (UNPAD): Another Indonesia-based pharmacy faculty with full S1-S3 program offerings and active pharmaceutical research. Competes directly with FFUI for students, faculty, and ranking position in the QS WUR Pharmacy & Pharmacology subject.

Emerging players

• Faculty of Pharmacy, Universitas Hasanuddin (UNHAS): Another Indonesian pharmacy faculty with growing research output and regional focus on eastern Indonesia. Indirect competitor for student recruitment and a potential future partner for regional pharmaceutical research collaboration.
• Nara Institute of Science and Technology (NAIST): Japan-based research university with which FFUI is exploring double degree programs and micro/nanofluidic drug development research. Comparable in pharmaceutical biotechnology research focus, especially in drug delivery and biomedical engineering.

Market position

Strengths5 records

Weaknesses4 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@FFarmasiUI
• Instagraminstagram.com/ffui_official
• LinkedInlinkedin.com/company/faculty-of-pharmacy-universitas-indonesia

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Faculty of Pharmacy Universitas Indonesia